Injecto Polymers Reports Zero Deviation in IPO Fund Utilization for Q2FY27
Injecto Polymers Ltd 路 Others (Uncategorized) 路 11 Nov 2026, 11:19 pm
Injecto Polymers Reports Zero Deviation in IPO Fund Utilization for Q2FY27 Injecto Polymers Limited reported nil deviation or variation in the utilization of proceeds raised via its Initial Public Offer for the quarter ended 30th Sep'26. Out of the total Rs 56.12 crore raised, the company utilized Rs 19.32 crore up to 30th Sep'26. Deployments include Rs 4.88 crore toward debt repayment against an allocated Rs 10.00 crore, Rs 7.25 crore for general corporate purposes versus Rs 7.28 crore allocated, and Rs 7.19 crore for issue expenses against Rs 8.34 crore planned. Capex allocation of Rs 30.50 crore remains unspent.
Original exchange filing (PDF)
More announcements from Injecto Polymers Ltd
- Monitoring Agency Report 路 11 Nov 2026
- Outcome of Board Meeting - Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ''Listing Regulations") 路 11 Nov 2026
- Injecto Polymers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve for unaudited financial result. 路 11 Nov 2026
- Certificate of Investor Complaint 路 20 Oct 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Capital Square Finanial Services Pvt Ltd 路 23 Sept 2026
